IP Library Assignment 060464/0415
Patent Assignment
Reel/Frame 060464/0415

Assignment of Assignor's Interest

Recorded: 2022-07-08 Pages: 13
Assignor
SYNERGY PHARMACEUTICALS, INC.
Executed: 2019-03-04
Assignee
BAUSCH HEALTH IRELAND LIMITED
3013 LAKE DRIVE, CITYWEST BUSINESS CAMPUS, DUBLIN, 24, IRELAND
Covered Properties (2)
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Patent: 8,969,514 →
Application: 12/630,654 →
Publication: US 2010/0152118
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application: 15/924,940 →
Publication: US 2018/0207229
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Sep 5, 2017
From: SYNERGY PHARMACEUTICALS INC.
To: CRG SERVICING LLC, AS AGENT
Reel/Frame 043488/0741 →
Security Interest Dec 10, 2018
From: SYNERGY PHARMACEUTICALS INC.
To: CRG SERVICING LLC
Reel/Frame 047729/0951 →
Assignment of Assignor's Interest Jan 24, 2019
From: COMISKEY, STEPHEN; FENG, RONG; FOSS, JOHN; SHAILUBHAI, KUNWAR
To: SYNERGY PHARMACEUTICALS, INC.
Reel/Frame 048124/0096 →
Release of Security Interest Mar 6, 2019
From: CRG SERVICING LLC
To: SYNERGY PHARMACEUTICALS INC.
Reel/Frame 048521/0005 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Interest Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (Second Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Security Agreement (First Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
U.S. Patent Security Agreement Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →